Skip to main content
OpenTrials
Completed

NCT Number: NCT04716972

Evaluating the Impact of COVID-19 (Coronavirus) on Research in Care Homes

During the COVID-19 (corona virus) pandemic the research arena has had to rapidly adapt and change in order to facilitate and deliver research. The UK (United Kingdom) government and Public Health England have stressed the importance of such research to find solutions to treating, preventing and stopping the spread of COVID-19. Due to national and international 'lock down restrictions' delivering research in care home settings has become even more challenging. The adaptations to conducting consultations have relied heavily on the use of technology, for example video calling, telephone, email, and teleconferencing. It is suggested that the use of technology in care home settings is already a barrier to effective research delivery.

Nevertheless, as care home residents are a vulnerable group, it is critical to include these groups in research in order to enable improved and evidence-based care and their access to new and emerging treatments.

This study aims to assess the opinions and experiences of key stakeholders to identify barriers, and enable better facilitation of research in these settings during and post pandemic.

Completed

Looking for future studies?

Notify Me

Key information

Sex eligibility

All sexes

Study type

Observational

Primary location

The Royal Wolverhampton NHS Trust

Wolverhampton, United Kingdom

About this study

This two phase project will use a mixed methodology.

Phase one will involve mixed methods surveys. One will be completed by care home residents and the other will be completed by research delivery staff and care home staff.

Phase two will involve qualitative interviews with each of these groups to enable better insight into their views and opinions on research in this area.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Any resident of a care home in the West Midlands
  • Any relative/friend of a care home resident in the West Midlands
  • Any staff member or volunteer working in care home in the West Midlands
  • Any researcher undertaking research in a care home in the West Midlands (during the pandemic or proposed during the pandemic period)

Exclusion criteria

  • Individuals who are unable to give Informed Consent
  • Individuals who lack capacity

Treatment and study plan

Survey

Other

Online survey

interview

Other

Interview

Primary outcomes

  1. Acceptability of vaccine studies in the care home setting through feedback questionnaire with loose themes and no unique measurements.

    Time frame: 6 months

    To inform the design and delivery of vaccine studies in the care home setting, ensuring they are acceptable by key stakeholders

  2. Acceptability of vaccine studies in the care home setting through feedback interview with loose themes and no unique measurements

    Time frame: 6 months

    To inform the design and delivery of vaccine studies in the care home setting, ensuring they are acceptable by key stakeholders

  3. Acceptability of new ways of delivering research through explorative interview with loose themes and no unique measurements

    Time frame: 6 months

    To inform and assess the acceptability of new ways of delivering research in care home settings, guiding changes and implementation of new ways of working moving forward

  4. Acceptability of new ways of delivering research through explorative questionnaire with loose themes and no unique measurements

    Time frame: 6 months

    To inform and assess the acceptability of new ways of delivering research in care home settings, guiding changes and implementation of new ways of working moving forward

Sponsors and collaborators

Lead sponsor

The Royal Wolverhampton Hospitals NHS Trust

Other Gov

Registry information

Official study title

Evaluating the Impact of COVID-19 on Research in Care Homes

Important dates

Study start
2021
Primary completion
2022
Study completion
2022
First posted
Jan 20, 2021
Registry last updated
Nov 10, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.